NCI Center for Cancer Research’s Post

Exciting new commentary by our Conquering KRAS in Pancreatic Cancer TeamLab members, Dr. Anirban Maitra from MD Anderson Cancer Center and Dr. Andrew J. Aguirre from Dana-Farber Cancer Institute is now published in Cancer Research, an American Association for Cancer Research journal. The commentary highlights that advancements in KRAS inhibition for pancreatic cancer are driven by strong collaborations!    “The current 'revolution' in KRAS inhibition was made possible by partnerships between oncologists and pathologists, cancer biologists and chemists, and academia and biotech—a spirit of collaboration motivated by the importance of the problem at hand."   Read more here: https://lnkd.in/epwWYw-6   #RadicalCollaboration #CancerResearch 

"Since Brexit, it was not possible for UK (based) researchers to access such large-scale grants. I think its great news that the UK has rejoined the Horizon (Europe) programme. It makes the country more attractive for international researchers such as me, especially at the early career stage." Comments from astrophysicist Clement Bonnerot, at the University of Birmingham, who will use new ERC Starting Grant funding to investigate what happens when supermassive black holes tear stars apart. Mishal Hussain of BBC radio 4, interviewed Evangelos Giampazolias and Clement Bonnerot, two recent winners of ERC Starting Grant. Evangelos Giampazolias's new research project will be based at The University of Manchester. He agreed with Hussain that he would not have been able to access this (ERC) funding before this (at least not while working from the UK). He said: "Its an incredible honour being funded by the ERC. Basically this complements my funding from Cancer Research UK, and allows me to interact with scientists across the globe." When the new batch of awardees were announced last week, ERC President Maria Leptin noted: "I am particularly pleased to welcome UK researchers back to the ERC. They have been sorely missed over the past years. With fifty grants awarded to researchers based in the UK, this influx is good for the research community overall." More on the 494 Starting Grants (worth 780 million euro) that were recently award by the European Research Council (ERC) 👉 https://lnkd.in/dg6BhxBD #EUfunded #FrontierResearch #ERCStG BBC Cancer Research UK Manchester Institute UK Research Office (UKRO) EU Science, Research and Innovation

Discover the Future of Cancer Treatment! We're thrilled to welcome three distinguished speakers to IMES2024: 🔬 Dr. Dennis E. Discher, PhD | University of Pennsylvania “Chromosomal instability in cancer can enhance macrophage-initiated immune responses, including anti-tumor IgG” 🧬 Dr. Matthew VanBrocklin, PhD | University of Utah “Development and application of a novel theralytic virus” Dr. Alessandro Fatatis, MD, PhD | Drexel University “Tumor-derived IL-1beta in metastatic prostate cancer” 🚀 Limited Seats Available—Secure Your Spot NOW: https://lnkd.in/e7wtW4XY 📢 Submit Your Abstract (Deadline is Oct. 1): https://lnkd.in/eQcYqi27 📚 Learn More: https://lnkd.in/eH2ZhQAm Don’t miss these pivotal talks shaping the future of cancer treatment! 🌟 #IME2024 #CancerResearch #BiomedicalEngineering #ScientificInnovation #ResearchLeadership

🗞️ Researchers have shown their simple system, called the Manchester Score, could help to improve detection rates of people at an increased risk of developing breast cancer. They found that the Manchester Score, which was developed at Manchester University NHS Foundation Trust (MFT), can identify more breast cancer patients who are eligible for testing for inherited faulty genes that can cause breast cancer. They analysed more than 1,000 DNA samples from women at MFT for this Manchester BRC-funded study. The study was led by Prof Dafydd Gareth Evans, Cancer Prevention and Early Detection Co-Theme Lead at Manchester BRC, who developed the Manchester Score. Read more 👇 https://lnkd.in/egHtznif #BreastCancerAwarenessMonth MFT Research and Innovation | NIHR (National Institute for Health and Care Research)

Today, September 24, is World Cancer Research Day. World Cancer Research Day aims to highlight the shared goals of improving the quality of life and survival for people with cancer, reducing the global impact of cancer, increasing access to research results, reducing disparities in cancer outcomes, and the importance of innovation in all aspects of cancer research, from prevention to treatment.  At WCG, we are proud to partner with, and lead the charge alongside, the heroes who help make innovation and breakthroughs in cancer research possible. Discover how WCG is optimizing the modern Oncology clinical trial process at https://lnkd.in/eEZcmUuh #WCRD #WorldCancerResearchDay #WCG #cancerresearch #clinicaltrial #clinicalresearch 

Ajay Chari, MD, of UCSF Helen Diller Family Comprehensive Cancer Center, Noopur Raje, MD, of Mass General Cancer Center, @Adriana Rossi, MD, of Weill Cornell Medicine, Natalie Callander, MD, of University of Wisconsin-Madison and Tom Martin, MD of UCSF Helen Diller Family Comprehensive Cancer Center discuss findings from the PERSEUS trial and the recent cytogenetic risk analysis for patients with newly diagnosed transplant-eligible multiple myeloma. Watch more here: https://lnkd.in/gsNHGKCX

I am happy to announce that Springer Nature's BMC Cancer has opened the “Genomic instability in cancer” Collection that I guest edit together with Albert Agustinus. Genomic instability is a hallmark of cancer and plays a critical role in its development and progression. Various pathways are known to contribute to genomic instability and it is important for us to continue advancing our collective understanding in this area to identify novel therapeutic targets, develop personalized cancer prevention strategies, and improve patient outcomes. With this in mind, submissions of papers on this topic are welcome at https://lnkd.in/dM7k748c Submission Deadline: 19August 2025 #cancer, #BMC

📅 Upcoming Events from the National Cancer Institute (NCI) 📅 The National Cancer Institute (NCI) is hosting key events, including a webinar on October 8 featuring Drs. Cari Kitahara and Choonsik Lee discussing the NCI Pediatric Proton and Photon Therapy Comparison Cohort. Additionally, the Cancer Research Data Commons Fall Symposium will take place on October 16-17, focusing on NCI’s AI Data Readiness Initiative and a collaboration with ARPA-H to develop a Biomedical Data Fabric Toolbox. These events present valuable opportunities for engagement in cancer research advancements. https://lnkd.in/eWCgATiB #CancerResearch #OncoDaily #Oncology #Cancer #Health #Medicine

For our third part in the ASCO recap highlighting NFCR-associated scientists, we are highlighting Himisha Beltran, M.D. On June 3rd, during the Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers session, Dr. Beltran presented an update on her research study targeting T-cell engagers in patients with small cell lung cancer and other neuroendocrine cancers. Dr. Beltran’s research is yielding tremendous results. We look forward to continuing our support of her groundbreaking research! To help make cures possible and continue the work that these excellent researchers are doing, visit https://lnkd.in/egA25rnh #NFCR #makecurespossible #cancerresearch #cancer #research #cancerresearcher #researchscientists #breakthrough #cancertreatment #fightcancer #beatcancer #curecancer #cancerfree #cancersupport #cancervurvivor #cancerawareness Harvard Medical School Dana-Farber Cancer Institute

Today is World Cancer Research Day — a reminder of the critical role research plays in transforming lives. At Breast Cancer Canada, we are dedicated to driving progress, working to improve patient outcomes and save lives. Every advancement we make is made possible by science and the support from donors like you. Together, we are moving closer to a future where breast cancer is managed with the least invasive and most effective personalized treatments. Join the progress at: breastcancerprogress.ca #breastcancerresearch